Literature DB >> 10658529

Familial testicular cancer in a single-centre population.

D J Sonneveld1, D T Sleijfer, H Schrafford Koops, R H Sijmons, W T van der Graaf, W J Sluiter, H J Hoekstra.   

Abstract

Familial occurrence of testicular cancer suggests a genetic predisposition to the disease. A genetic susceptibility may also be reflected by the occurrence of bilateral testicular neoplasms and the high rates of urogenital developmental anomalies in families prone to testicular cancer. In this study, the proportion of familial testicular cancer cases was analyzed retrospectively in a single-centre population of 693 testicular cancer patients treated between 1977 and 1997 and the relative risk (RR) for first-degree relatives of patients was estimated. In addition, the existence of bilateral testicular neoplasms and urogenital developmental anomalies in familial testicular cancer patients was evaluated. 24 of the 693 patients (3.5%) had a first-degree relative with testicular cancer. These 24 cases belonged to 17 families; in 7 of these 17 families both affected first-degree family members were part of the study population of 693 patients. Consequently, the 693 studied patients belonged to a total of 686 families. Thus, the actual proportion of familial testicular cancer was 2.5% (17 of 686 families). The familial cases consisted of 11 brother pairs, including 2 pairs of identical twins and 1 pair which also had two affected cousins, and 6 father-son pairs (in total 36 cases, 12 treated elsewhere). Estimates of the RR to first-degree relatives showed a 9- to 13-fold increased RR to brothers (P < 0.001) and a 2-fold increased RR to fathers (P = non-significant (n.s)) of testicular cancer patients. Among the 36 patients with familial testicular cancer, 2 (5.6%) had bilateral testicular cancer, 4 (11.1%) had undescended testis, 3 (8.3%) had inguinal hernia, and 1 (2.8%) showed renal hypoplasia. The present data on familial occurrence of testicular cancer may lend support to a role of genetic factors in the aetiology of testicular cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10658529     DOI: 10.1016/s0959-8049(99)00140-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  21 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  Increased predisposition to cancer in brothers and offspring of testicular tumor patients.

Authors:  Sarolta Gundy; Mária Babosa; Márta Baki; István Bodrogi
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

3.  Constitutional cytogenetic analysis in men with hereditary testicular germ cell tumor: no evidence of disease-related abnormalities.

Authors:  Christine M Mueller; Larissa Korde; Hormuzd A Katki; Philip S Rosenberg; June A Peters; Mark H Greene
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

Review 4.  Transgenerational genetic effects on phenotypic variation and disease risk.

Authors:  Joseph H Nadeau
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

5.  Cancer in first-degree relatives and risk of testicular cancer in Denmark.

Authors:  Rikke Baastrup Nordsborg; Jaymie R Meliker; Jan Wohlfahrt; Mads Melbye; Ole Raaschou-Nielsen
Journal:  Int J Cancer       Date:  2011-03-04       Impact factor: 7.396

Review 6.  Adolescent and adult risk factors for testicular cancer.

Authors:  Katherine A McGlynn; Britton Trabert
Journal:  Nat Rev Urol       Date:  2012-04-17       Impact factor: 14.432

7.  Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group.

Authors:  Erin L Marcotte; Nathan Pankratz; James F Amatruda; A Lindsay Frazier; Mark Krailo; Stella Davies; Jacqueline R Starr; Ching C Lau; Michelle Roesler; Erica Langer; Caroline Hallstrom; Anthony J Hooten; Jenny N Poynter
Journal:  Genes Chromosomes Cancer       Date:  2017-04-04       Impact factor: 5.006

8.  A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility.

Authors:  Peter A Kanetsky; Nandita Mitra; Saran Vardhanabhuti; David J Vaughn; Mingyao Li; Stephanie L Ciosek; Richard Letrero; Kurt D'Andrea; Madhavi Vaddi; David R Doody; Joellen Weaver; Chu Chen; Jacqueline R Starr; Håkon Håkonarson; Daniel J Rader; Andrew K Godwin; Muredach P Reilly; Stephen M Schwartz; Katherine L Nathanson
Journal:  Hum Mol Genet       Date:  2011-05-06       Impact factor: 6.150

9.  Family history of cancer and malignant germ cell tumors in children: a report from the Children's Oncology Group.

Authors:  Jenny N Poynter; Amy H Radzom; Logan G Spector; Susan Puumala; Leslie L Robison; Zhi Chen; Julie A Ross; Xiao-Ou Shu
Journal:  Cancer Causes Control       Date:  2009-10-15       Impact factor: 2.506

10.  Clinical and genetic aspects of testicular germ cell tumours.

Authors:  Martijn F Lutke Holzik; Rolf H Sijmons; Josette Ehm Hoekstra-Weebers; Dirk T Sleijfer; Harald J Hoekstra
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.